BRCA1/2 Genetic Testing in the Community Setting
- 15 November 2002
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 20 (22), 4485-4492
- https://doi.org/10.1200/jco.2002.08.147
Abstract
PURPOSE: BRCA1/2 genetic testing has been commercially available in the United States since 1996. Most published reports described BRCA1/2 testing as research studies at large academic centers, but less is known about testing in the community. This study evaluates the process and early outcomes of BRCA1/2 genetic testing as a clinical service in the community setting. METHODS: Surveys were mailed to women in the United States whose health care providers ordered BRCA1/2 genetic testing from Myriad Genetic Laboratories from August 1998 through July 2000. Women tested at 149 large academic centers were excluded. Main outcome measures were demographic characteristics, recall of and satisfaction with the genetic testing process, and likelihood of pursuing cancer prevention strategies. RESULTS: Among the 646 respondents, 414 (64%) had a personal history of cancer and 505 (78%) had at least one first-degree relative with breast and/or ovarian cancer. Most subjects (82%) recalled discussions of informed consent before testing (median time, 30 minutes). Genetic results were conveyed during an office visit (57%), by telephone (39%), or by mail (3%). More than 75% of respondents were “very satisfied with the counseling received.” Cancer-free subjects with a germline mutation were more likely to consider prevention strategies after receiving the genetic results. CONCLUSION: Virtually all respondents had a personal and/or family history of breast/ovarian cancer. Although pretest and posttest communications were not standardized, overall satisfaction with clinical breast cancer genetic testing was high. Additional follow-up will provide data on future cancer prevention practices and cancer incidence.This publication has 30 references indexed in Scilit:
- Genetic counseling and testing for breast-ovarian cancer susceptibility: what do women want?Journal of Clinical Oncology, 1998
- BRCA1Mutations in Women Attending Clinics That Evaluate the Risk of Breast CancerThe New England Journal of Medicine, 1997
- Familial breast cancer: a controlled study of risk perception, psychological morbidity and health beliefs in women attending for genetic counsellingBritish Journal of Cancer, 1996
- A Model Protocol for Evaluating the Behavioral and Psychosocial Effects of BRCA1 TestingJNCI Journal of the National Cancer Institute, 1996
- BRCA1 Testing in Families With Hereditary Breast-Ovarian CancerJAMA, 1996
- BRCA1— Lots of Mutations, Lots of DilemmasThe New England Journal of Medicine, 1996
- Identification of the breast cancer susceptibility gene BRCA2Nature, 1995
- Assessment and Counseling for Women With a Family History of Breast CancerJAMA, 1995
- A Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRCA1Science, 1994
- BRCA1 Mutations in Primary Breast and Ovarian CarcinomasScience, 1994